Seely Lynn 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Seely Lynn（CIK 1327111）在 2 家公司共报告 14 笔 SEC Form 4 内部人交易（最近一笔 2026-08-25）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-25 | Lyell Immunopharma, Inc. (LYEL) | President and CEO | 卖出 | 9,589 | $149,013 |
| 2026-08-11 | Lyell Immunopharma, Inc. (LYEL) | President and CEO | 卖出 | 390 | $5,593 |
| 2026-06-15 | Lyell Immunopharma, Inc. (LYEL) | President and CEO | 卖出 | 388 | $7,337 |
| 2026-02-12 | Lyell Immunopharma, Inc. (LYEL) | President and CEO | 卖出 | 7,455 | $174,372 |
| 2026-02-11 | Lyell Immunopharma, Inc. (LYEL) | President and CEO | 买入 | 20,000 | $0 |
| 2026-02-11 | Lyell Immunopharma, Inc. (LYEL) | President and CEO | 卖出 | 438 | $10,127 |
| 2025-11-12 | Lyell Immunopharma, Inc. (LYEL) | President and CEO | 卖出 | 412 | $6,637 |
| 2025-08-22 | Lyell Immunopharma, Inc. (LYEL) | President and CEO | 买入 | 40,000 | $0 |
| 2025-08-22 | Lyell Immunopharma, Inc. (LYEL) | President and CEO | 卖出 | 7,257 | $76,489 |
| 2025-08-13 | Lyell Immunopharma, Inc. (LYEL) | President and CEO | 卖出 | 391 | $4,117 |
| 2025-08-13 | Lyell Immunopharma, Inc. (LYEL) | President and CEO | 卖出 | 406 | $4,198 |
| 2025-07-21 | Blueprint Medicines Corp (BPMC) | 董事 | 卖出 | 13,254 | $0 |
| 2025-07-21 | Blueprint Medicines Corp (BPMC) | 董事 | 卖出 | 3,902 | $0 |
| 2025-06-24 | Blueprint Medicines Corp (BPMC) | 董事 | 买入 | 3,902 | $499,924 |
来源：SEC Form 4 申报文件 · 截至 2026-08-25